SCHEMBL14579858

SCHEMBL14579858

COC(=O)CN(Cc1ccc(Cl)cc1)C1CCN(CC/C=C2\C3=CC=CNC3COC3=C2CC(C(C)(C)O)C=C3)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13824457 0.77 BCHE (0.36) —
SCHEMBL18895954 0.76 CCR1 (0.37) —
SCHEMBL18895964 0.75 — —
SCHEMBL18895955 0.73 CCR1 (0.38) —
SCHEMBL13824455 0.73 — —
SCHEMBL18633823 0.71 NR1D1 (0.32) —
SCHEMBL18633826 0.68 CHRM2 (0.39) —
SCHEMBL655056 0.66 CCR1 (0.58) —
SCHEMBL655057 0.66 CCR1 (0.58) —
SCHEMBL14420171 0.66 CCR1 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070060592-A1 heterocylic amines such as 2-(5-{3-[4-(4-Chloro-2-methyl-phenyl)-piperazin-1-yl]-propylidene}-5,11-dihydro-10-oxa-1-aza-dibenzo[a,d]cyclohepten-7-yl)-propan-2-ol, used for treating diseases associated with aberrant leukocyte recruitment and/or activation MILLENNIUM PHARMACEUTICALS, INC. 2007-03-15 — — US disclosed
Send feedback